The Final Report of the USA CAPO Registry summarizes eight years of observation and analysis that reflects the experiences of 485 clinical centers and over 25,000 CAPO patients. As such, it offers a wealth of information, available here for the first time to interested parties around the world. Because the National Institutes of Health was quick to see the potential of CAPO as a promising therapy for patients with end stage renal disease, the Registry project was begun soon after its introduction into clinical practice in the USA. Accordingly, the Registry offered the nephrology community in the United States a special opportunity to study this emerging new therapy in some detail, an opportunity not previously available for any other form of dialysis. As will be seen in this report, the result of this early and intensive research effort has been the development of a vast amount of clinically important information regarding the utilization, safety, and efficacy of this important dialytic therapy.

Inhalt
Section 1 Introduction.- Section 2 Registry Patient Population.- Section 3 Patient Characteristics.- Section 4 Complications of Treatment.- Section 5 Termination of Continuous Peritoneal Dialysis.- Section 6 Special Reports1988.- Section 7 Special Reports1987.- Section 8 Special Reports1986.- Section 9 Special Report1985.- Section 10 Special Report1984.- Appendices.- I. Executive Advisory Committee of the National CAPD Registry of the National Institutes of Health.- II. Participating Centers of the National CAPD Registry of the National Institutes of Health.- III. Bibliography of the National CAPD Registry of the National Institutes of Health.- Table of Exhibits.- Section 2 Registry Patient Population.- Exhibit 2-1 Number of Patients Registered by Class and Type of Dialysis.- 2-2 Number of Patients Registered by Class and Year of Registration.- 2-3 Number of Patients with Follow-up by Class and Type of Dialysis.- 2-4 Last Contact and Status According to Activity Classification of Center for Patients Last Reported to be on CAPD/CCPD.- 2-5 Currency of The National CAPD Registry Database by Class of Patient.- 2-6 Number of Patients Receiving CAPD at Year End.- 2-7 Census and Flow of The National CAPD Registry by Year.- Section 3 Patient Characteristics.- Exhibit 3-1 Percent of Patients with Selected Characteristics by Type of Therapy.- 3-2 CAPDAge Distribution by Sex.- 3-3 CCPDAge Distribution by Sex.- 3-4 CAPDAge Distribution by Race.- 3-5 CCPDAge Distribution by Race.- 3-6 CAPDDistribution of Patients by Primary Renal Disease Type According to Year of Registration.- Section 4 Complications.- Exhibit 4-1 CAPDOccurrence of Selected Complications by Class of Patients.- 4-2 CAPDCumulative Probability of Experiencing First Episode ofPeritonitis (Class 1 Patients Only).- 4-3 CAPDComplication Rates by Year of Registration.- 4-4 CAPDCumulative Probabilities and 95% Confidence Intervals (C.I.) of Experiencing Selected Events for the First Time by Year Registered (Class 1 Patients Only).- 4-5 CAPDCumulative Probability of Experiencing First Exit Site/Tunnel Infection (Class 1 Patients Only).- 4-6 CAPDCumulative Probability of First Catheter.- Replacement (Class 1 Patients Only).- 4-7 CAPDCumulative Probability of First Complication (Class 1 Patients Only).- 4-8 CCPDOccurrence of Selected Complications by.- Class of Patient.- 4-9 CCPDCumulative Probabilities and 95% Confidence Intervals (C.I.) of Experiencing Selected Events for the First Time by Number of Months on CCPD (Class 1 Patients Only).- Section 5 Termination of Continuous Peritoneal Dialysis.- Exhibit 5-1 CAPDCumulative Probability of Transfer (Class 1 Patients Only).- 5-2 CAPDCumulative Probability of Receiving a Kidney Transplant (Class 1 Patients Only).- 5-3 CAPDCumulative Probability of Death (Class 1 Patients Only).- 5-4 CAPDCumulative Probability of Discontinuing CAPD Therapy for any Reason (Class 1 Patients Only).- 5-5 CCPDCumulative Probability of Transfer (Class 1 Patients Only).- 5-6 CCPDCumulative Probability of Receiving a Kidney Transplant (Class 1 Patients Only).- 5-7 CAPDCumulative Probability of Death (Class 1 Patients Only).- 5-8 CCPDCumulative Probability of Discontinuing CCPD Therapy for Any Reason (Class 1 Patients Only).- 5-9 CAPD or CCPDCumulative Probability of Transplantation: Pediatrics vs. 'Standard' vs. 'Other'.- 5-10 CAPD or CCPDCumulative Probability of.- Death: Pediatrics vs. 'Standard' vs. 'Other'.- 5-11 CAPD or CCPDCumulative Probability of'Technique Failure': Pediatrics vs. 'Standard' vs. 'Other'.- 5-12 Follow-up of Transfers to Hemodialysis Summary.- 5-13 Primary Reason for Leaving CAPD in Patients who Transferred from CAPD to Hemodialysis and Subsequently Returned to CAPD.- 5-14 Follow-up of Kidney Transplant Summary.- 5-15 Death Summary.